NCT05825833View on ClinicalTrials.gov

Infliximab Efficacy in Relation to Therapeutic Drug Monitoring and Serum TNFα Levels in Pediatric HSCT

CompletedOBSERVATIONAL

Enrollment

28

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

December 31, 2022

Study Completion Date

December 31, 2022

Conditions

Acute Graft-versus-host Disease

Trial Locations (1)

34137

IRCCS Burlo Garofolo, Trieste

All Listed Sponsors

lead

IRCCS Burlo Garofolo

OTHER